#sglt2-inhibitors

[ follow ]
#glp-1-medications #weight-loss #glp-1-drugs #glp-1-receptor-agonists #type-2-diabetes #glp-1 #obesity
#glp-1
SF food
fromwww.npr.org
1 week ago

What does a 'GLP-1 Friendly' diet look like? We asked nutritionists

Food companies are branding products as 'GLP-1 Friendly' to cater to consumers using obesity and diabetes medications.
Medicine
fromSlate Magazine
1 week ago

The Risk Too Many People Are Taking With Ozempic

GLP-1 receptor agonists, while effective for obesity and diabetes, may cause significant gastrointestinal issues and other health risks.
SF food
fromwww.npr.org
1 week ago

What does a 'GLP-1 Friendly' diet look like? We asked nutritionists

Food companies are branding products as 'GLP-1 Friendly' to cater to consumers using obesity and diabetes medications.
Medicine
fromSlate Magazine
1 week ago

The Risk Too Many People Are Taking With Ozempic

GLP-1 receptor agonists, while effective for obesity and diabetes, may cause significant gastrointestinal issues and other health risks.
more#glp-1
#obesity
Medicine
fromWIRED
2 days ago

FDA Approves Eli Lilly's GLP-1 Pill

The FDA approved Foundayo, a new daily obesity pill by Eli Lilly, expanding options for weight loss treatments alongside injectable GLP-1 medications.
Medicine
fromWIRED
2 days ago

FDA Approves Eli Lilly's GLP-1 Pill

The FDA approved Foundayo, a new daily obesity pill by Eli Lilly, expanding options for weight loss treatments alongside injectable GLP-1 medications.
more#obesity
#glp-1-drugs
Medicine
fromFuturism
1 week ago

Scientists Just Found Something Rather Grim That Happens When You Stop Taking GLP-1s

Stopping GLP-1 drugs can quickly reverse health benefits, increasing cardiovascular risks and leading to weight regain and other health issues.
Medicine
fromwww.scientificamerican.com
2 weeks ago

The GLP-1 saga is only getting juicier and messier

The FDA warned Novo Nordisk about failing to disclose risks and report deaths linked to semaglutide, while GLP-1 drugs surge in popularity for diabetes and weight loss despite unapproved market alternatives.
Medicine
fromwww.npr.org
4 weeks ago

GLP-1 drugs like Ozempic can curb addiction risk, study finds

GLP-1 drugs reduce substance abuse disorder risk and overdose deaths by 15-20% across multiple addictive substances including opioids, alcohol, and cocaine.
Medicine
fromwww.npr.org
3 weeks ago

GLP-1s have transformed weight loss and diabetes. Is addiction next?

GLP-1 drugs reduce substance misuse risk by 15-20% and lower overdose, hospitalization, and death rates in people with addiction history.
fromFortune
4 weeks ago
Medicine

GLP-1s cure hunger for a lot more than food, my study of 600,000 people suggests | Fortune

Medicine
fromFuturism
1 week ago

Scientists Just Found Something Rather Grim That Happens When You Stop Taking GLP-1s

Stopping GLP-1 drugs can quickly reverse health benefits, increasing cardiovascular risks and leading to weight regain and other health issues.
Medicine
fromwww.scientificamerican.com
2 weeks ago

The GLP-1 saga is only getting juicier and messier

The FDA warned Novo Nordisk about failing to disclose risks and report deaths linked to semaglutide, while GLP-1 drugs surge in popularity for diabetes and weight loss despite unapproved market alternatives.
Medicine
fromwww.npr.org
4 weeks ago

GLP-1 drugs like Ozempic can curb addiction risk, study finds

GLP-1 drugs reduce substance abuse disorder risk and overdose deaths by 15-20% across multiple addictive substances including opioids, alcohol, and cocaine.
Medicine
fromwww.npr.org
3 weeks ago

GLP-1s have transformed weight loss and diabetes. Is addiction next?

GLP-1 drugs reduce substance misuse risk by 15-20% and lower overdose, hospitalization, and death rates in people with addiction history.
fromFortune
4 weeks ago
Medicine

GLP-1s cure hunger for a lot more than food, my study of 600,000 people suggests | Fortune

more#glp-1-drugs
#glp-1-receptor-agonists
Medicine
fromwww.theguardian.com
2 weeks ago

GLP-1 diabetes drugs could stop anxiety and depression worsening, study finds

GLP-1 receptor agonists, particularly semaglutide and liraglutide, reduce the risk of worsening anxiety and depression in people with diabetes.
Medicine
fromwww.theguardian.com
2 weeks ago

GLP-1 diabetes drugs could stop anxiety and depression worsening, study finds

GLP-1 receptor agonists, particularly semaglutide and liraglutide, reduce the risk of worsening anxiety and depression in people with diabetes.
more#glp-1-receptor-agonists
Medicine
fromwww.scientificamerican.com
2 weeks ago

Experimental GLP-3 weight loss drug retatrutide shows promising results in clinical trial

Retatrutide, a triple-receptor GLP-3 agonist drug, achieved up to 36.6 pounds of average weight loss and improved blood sugar control in phase 3 clinical trials for type 2 diabetes.
#glp-1-medications
Medicine
fromFast Company
3 weeks ago

Experts warn that GLP-1s are leading to the resurgence of a 17thcentury disease

GLP-1 drugs suppress appetite without ensuring proper nutrition, causing severe vitamin deficiencies and diseases like scurvy in users.
Public health
fromInsideHook
2 months ago

Research Suggests GLP-1 Drugs Could Be for the Long Haul

People using GLP-1 weight-loss medications often require long-term or lifelong treatment because stopping them commonly leads to rapid weight regain and lost metabolic benefits.
Medicine
fromScienceDaily
2 weeks ago

What happens after Ozempic shocked researchers

Stopping GLP-1 medications like Ozempic does not typically lead to significant weight regain, as many patients switch treatments or restart therapy.
Medicine
fromPsychology Today
2 weeks ago

The Psychology of Ozempic

GLP-1 drugs reduce appetite and desire but may dampen all desires including healthy ones, potentially creating depression-like symptoms and reducing motivation for work, relationships, and life satisfaction.
Medicine
fromFast Company
3 weeks ago

Experts warn that GLP-1s are leading to the resurgence of a 17thcentury disease

GLP-1 drugs suppress appetite without ensuring proper nutrition, causing severe vitamin deficiencies and diseases like scurvy in users.
more#glp-1-medications
Medicine
fromwww.scientificamerican.com
2 weeks ago

Drugs like Ozempic are improving kidney treatment and changing lives

GLP-1 receptor agonists, finerenone, and SGLT2 inhibitors represent breakthrough treatments for chronic kidney disease, with combined therapy potentially adding decades to patients' lives.
fromwww.theguardian.com
4 weeks ago

Weight-loss jab could be made for $3 a month, study finds

New research, published as a pre-print, suggests that semaglutide could be mass produced for $3 (about 2.35) for a monthly dose in its injectable form. Newer formulations, taken as a pill rather than an injection, could be made for about $16 a month.
Medicine
Health
fromBusiness Insider
2 months ago

My two weeks in sugar jail

Continuous glucose monitoring reveals blood sugar fluctuations, but limited evidence links stabilizing glucose in healthy people to sustained energy improvement or weight loss.
#glp-1-agonists
more#glp-1-agonists
[ Load more ]